Reports for GE HEALTHCARE CANADA INC

Company Name

GE HEALTHCARE CANADA INC

Totals

Shortage reports

70
Actual shortage: 0 (0%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (7%)
Resolved: 65 (93%)

Discontinuation Reports

5
To be discontinued: 0 (0%)
Discontinued: 5 (100%)
Reversed: 0 (0%)

Late reports

0 (0%)

Overdue reports

0 (0%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ADREVIEW 74MBq SOLUTION Resolved 2020-09-18 2020-09-21 124542
OMNIPAQUE 240 518MG SOLUTION Resolved 2020-08-14 2020-09-15 122257
INDIUM DTPA IN 111 37MBq SOLUTION Avoided shortage 2020-01-28 2020-05-19 104510
OMNISCAN 287MG SOLUTION Resolved 2019-10-11 2019-11-06 96322
OMNISCAN 287MG SOLUTION Resolved 2019-09-24 2019-11-01 94587
OMNISCAN 287MG SOLUTION Resolved 2019-09-10 2019-09-17 93472
OMNIPAQUE 240 518MG SOLUTION Resolved 2019-06-19 2019-06-22 87081
OMNIPAQUE 240 518MG SOLUTION Resolved 2019-06-06 2019-06-14 85726
Technetium Tc 99m TSC not applicable Reaction vial - lyophilized form; Components - Solution A and Solution B Resolved 2017-06-27 2017-07-06 14093
Technetium Tc 99m TSC 1 mCi/mL Solution Resolved 2017-06-29 2017-07-04 14396

Showing 61 to 70 of 70

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OMNISCAN 287MG SOLUTION Discontinued 2023-01-31 2023-03-25 182742
OMNIPAQUE 240 518MG SOLUTION Discontinued 2023-01-31 2023-03-18 182760
OMNIPAQUE 180 388MG SOLUTION Discontinued 2023-01-31 2023-02-22 182757
THALLOUS CHLORIDE TI 201 INJECTION 37MBq SOLUTION Discontinued 2020-12-04 2021-06-05 129592
Metastron 37 MBq/mL Solution Discontinued 2018-10-12 2019-02-01 63929

Showing 1 to 5 of 5